Viablife Biolego® Platform
By integrating AI, industrial informatics (IT), and big data, Viablife has created the the future-oriented “BT + IT + AI” smart biomanufacturing platform—Viablife Biolego® Platform. This platform expands Viablife’s proprietary strain library with independent intellectual property advantages. By enabling diverse combinations and adaptation of curated biological components and leveraging China’s first commercial AI-driven high-throughput validation system, the Qiji System, it provides 24/7 intelligent validation and real-time data uploading. The platform continuously enhances synthetic biology metabolic pathways and generates high-value compound synthesis data to support customers’ commercial development needs.
Leveraging the Viablife Biolego® Platform, Viablife has developed dozens of chassis cell factories—including bacilli, cocci, actinomycetes, and yeasts—unlocking versatile solutions for diverse products and applications.
Today, Viablife has established a library of over 1,000 high-efficiency proteases and their gene sequences, all exclusive to the Viablife Biolego® Platform. We have also developed the proprietary Wukong System to analyze the potential correlations between diverse protein structures and their functions, enabling precise directed evolution.